– USA, TX – Itafos Inc. (TSX: IFOS) today announced the appointments of Stephen Shapiro and Isaiah Toback to its Board of Directors, effective April 14, 2022.
Mr. Toback replaces Rory O’Neill as a nominee to the Board of Directors by its principal shareholder, CL Fertilizers Holding LLC.
“We are pleased to welcome Stephen and Isaiah to our Board. Both appointments add to the overall depth and skill set of the Board and will be instrumental in providing oversight as the Company continues to execute on of its strategic initiatives,” said Board Chairman, Anthony Cina.
About Stephen Shapiro
Mr. Shapiro is CFO at Cellview Imaging Inc., an emerging medical device company. Prior to joining Cellview, Mr. Shapiro had a 30 year career in investment banking, most recently leading the Canadian Industrials and Consumer Group for Wells Fargo Securities Canada. Prior to joining Wells Fargo, Mr. Shapiro spent 13 years with BMO Capital Markets, where he started and led the Agriculture and Fertilizer Group. Mr. Shapiro is a Chartered Financial Analyst.
Mr. Shapiro holds a bachelor of commerce from McGill University and a Master of Business Administration from the University of Chicago.
About Isaiah Toback
Mr. Toback is a partner at Castlelake and is deputy co-CIO. Mr. Toback is responsible for guiding and executing the firm’s global investment strategy across asset classes, overseeing the firm’s value and income fund portfolios and supporting the growth and development of its investment teams. He is also a voting member of the firm’s Investment Review Committee. Mr. Toback became a partner of the firm in 2020 and previously served in portfolio management and investment roles. He has particular experience with investments in dislocated industries and corporate special situations, including leading the firm’s renewables and commodity shipping strategies. Prior to joining Castlelake, Mr. Toback was an investment banker with Goldman Sachs, where he was responsible for transportation structured financings, focusing on the aviation and shipping industries. Mr. Toback holds a bachelor of arts in economics from Vanderbilt University.
About Itafos
The Company is a phosphate and specialty fertilizer company. The Company’s businesses and projects are as follows:
- Conda – a vertically integrated phosphate fertilizer business with a production capacity of approximately 550kt per year of monoammonium phosphate, MAP with micronutrients, super phosphoric acid, merchant grade phosphoric acid, and ammonium polyphosphate located in Idaho, US;
- Arraias – a vertically integrated phosphate fertilizer business with production capacity of approximately 500kt per year of single superphosphate, SSP with micronutrients and approximately 40kt per year of excess sulfuric acid (220kt per year gross sulfuric acid production capacity) located in Tocantins, Brazil;
- Farim – a high-grade phosphate mine project located in Farim, Guinea-Bissau;
- Santana – a vertically integrated high-grade phosphate mine and fertilizer plant project located in Pará, Brazil; and
- Araxá – a vertically integrated rare earth elements and niobium mine and extraction plant project located in Minas Gerais, Brazil.
In addition to the businesses and projects described above, the Company also owns Paris Hills and Mantaro, which are phosphate mine project that are in process of being would down.
The Company is a Delaware corporation that is headquartered in Houston, TX. The Company’s shares trade on the TSX Venture Exchange under the ticker symbol “IFOS”. The Company’s principal shareholder is CLF. CLF is an affiliate of Castlelake, L.P., a global private investment firm.
For more information: https://www.itafos.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.